收费全文 | 197篇 |
免费 | 0篇 |
国内免费 | 9篇 |
安全科学 | 12篇 |
废物处理 | 19篇 |
环保管理 | 9篇 |
综合类 | 23篇 |
基础理论 | 34篇 |
污染及防治 | 81篇 |
评价与监测 | 18篇 |
社会与环境 | 9篇 |
灾害及防治 | 1篇 |
2023年 | 6篇 |
2022年 | 28篇 |
2021年 | 18篇 |
2020年 | 5篇 |
2019年 | 12篇 |
2018年 | 5篇 |
2017年 | 12篇 |
2016年 | 9篇 |
2015年 | 6篇 |
2014年 | 16篇 |
2013年 | 17篇 |
2012年 | 12篇 |
2011年 | 9篇 |
2010年 | 5篇 |
2009年 | 5篇 |
2008年 | 13篇 |
2007年 | 6篇 |
2006年 | 6篇 |
2005年 | 1篇 |
2004年 | 2篇 |
2003年 | 5篇 |
2002年 | 1篇 |
2000年 | 1篇 |
1989年 | 1篇 |
1985年 | 1篇 |
1968年 | 1篇 |
1966年 | 1篇 |
1964年 | 2篇 |
Methods: A cross-sectional study involving 1,049 individuals (age 18–75 years) who are actively driving vehicles and taking at least one medication known to affect driving (anxiolytics, antidepressants, hypnotics, antiepileptics, opioids, sedating antihistamines, hypoglycemic agents, antihypertensives, central nervous system [CNS] stimulants, and herbals with CNS-related effects) was conducted in Amman, Jordan, over a period of 8 months (September 2013–May 2014) using a structured validated questionnaire.
Results: Sixty-three percent of participants noticed a link between a medicine taken and feeling sleepy and 57% stated that they experience at least one adverse effect other than sleepiness from their medication. About 22% of the participants reported having a MVC while on medication. Multiple logistic regression analysis showed that among the participants who reported having a crash while taking a driving-impairing medication, the odds ratios were significantly higher for the use of inhalant substance (odds ratio [OR] = 2.787, P = .014), having chronic conditions (OR = 1.869, P = .001), and use of antiepileptic medications (OR = 2.348, P = .008) and significantly lower for the use of antihypertensives (OR = 0.533, P = .008).
Conclusion: The study results show high prevalence of adverse effects of medications with potential for driving impairment, including involvement in MVCs. Our findings highlight the types of patient-related and medication-related factors associated with MVCs in Jordan, such as inhalant use, presence of chronic conditions, and use of antiepileptics. 相似文献
Access to drinkable water is becoming more and more challenging due to worldwide pollution and the cost of water treatments. Water and wastewater treatment by adsorption on solid materials is usually cheap and effective in removing contaminants, yet classical adsorbents are not sustainable because they are derived from fossil fuels, and they can induce secondary pollution. Therefore, biological sorbents made of modern biomass are increasingly studied as promising alternatives. Indeed, such biosorbents utilize biological waste that would otherwise pollute water systems, and they promote the circular economy. Here we review biosorbents, magnetic sorbents, and other cost-effective sorbents with emphasis on preparation methods, adsorbents types, adsorption mechanisms, and regeneration of spent adsorbents. Biosorbents are prepared from a wide range of materials, including wood, bacteria, algae, herbaceous materials, agricultural waste, and animal waste. Commonly removed contaminants comprise dyes, heavy metals, radionuclides, pharmaceuticals, and personal care products. Preparation methods include coprecipitation, thermal decomposition, microwave irradiation, chemical reduction, micro-emulsion, and arc discharge. Adsorbents can be classified into activated carbon, biochar, lignocellulosic waste, clays, zeolites, peat, and humic soils. We detail adsorption isotherms and kinetics. Regeneration methods comprise thermal and chemical regeneration and supercritical fluid desorption. We also discuss exhausted adsorbent management and disposal. We found that agro-waste biosorbents can remove up to 68–100% of dyes, while wooden, herbaceous, bacterial, and marine-based biosorbents can remove up to 55–99% of heavy metals. Animal waste-based biosorbents can remove 1–99% of heavy metals. The average removal efficiency of modified biosorbents is around 90–95%, but some treatments, such as cross-linked beads, may negatively affect their efficiency.
相似文献